Associate Marketing Manager – Japan CRC will be responsible for driving the Natera's first commercial oncology strategy in CRC based on GALAXY study and its two relevant studies (Vega and Altair) and marketing execution in one of the most critical global markets. This role will lead the launch and growth of Signatera in CRC, working at the intersection of innovation, science, and market need. This individual will also lead patient-centered initiatives, including public awareness campaigns and partnerships with advocacy organizations, to increase education around cancer recurrence monitoring and the benefits of personalized testing of in CRC.

Key Responsibilities:

• Strategic Marketing Leadership in CRC

• Develop and execute Natera's oncology marketing strategy for Japan, aligned with global objectives and tailored to local market dynamics.

• Drive go-to-market planning and execution for Signatera CRC based on GALAXY studay including pricing, positioning, segmentation, and messaging.

• Manage brand planning, forecasting, and marketing investment decisions to drive

• Adoption and revenue growth.

• Market Development & Education in CRC

• Partner with Medical Affairs and Sales to educate clinicians, oncologists, and KOLs on the clinical utility and value proposition of Signatera.

• Build awareness and demand through omni-channel campaigns, peer-to-peer education, and congress activities in major CRC congresses (such as JSCO, JSMO, JSGS and JSCCR).

• Patient Education & Advocacy Engagement to CRC patients

• Lead the design and implementation of patient education initiatives, ensuring patients and caregivers understand the role of ctDNA testing in cancer care.

• Establish and manage partnerships with patient advocacy groups and cancer support organizations to develop co-branded materials, host educational events, and improve outreach.

• Develop and execute public awareness campaigns to increase understanding of cancer recurrence monitoring and non-invasive testing options.

• Ensure all patient-facing materials meet ethical and regulatory standards in Japan.

• Launch Readiness & Execution for CRC-GALAXY launch

• • Drive launch readiness activities including market research, field force enablement,

  • KOL engagement, and public affairs support.

  • Collaborate with Market Access and HEOR teams to support patient access and reimbursement pathways.

• Cross-Functional Collaboration

• • Act as the voice of the Japanese market in global marketing and product discussions.

  • Coordinate closely with global marketing, regulatory affairs, market access, medical affairs, and commercial operations.

  • Manage external vendors and agencies to deliver impactful campaigns and programs.

Qualifications:

• Bachelor's degree in business, life sciences, or related field required; MBA or advanced degree preferred.

• 10 years of progressive marketing experience in life sciences or diagnostics, with at least 5 years in GI oncology within Japan.

• Demonstrated success in launching innovative healthcare products

• Strong understanding of the Japanese GI oncology and diagnostics ecosystem, including KOLs, patient organizations, and regulatory landscape.

• Business-level English and fluent Japanese required.

Preferred Attributes:

• Experience in molecular diagnostics, patient advocacy relations, or public health communications.

• Strong storytelling and brand positioning capabilities with a focus on both clinicians and patients.

• Passionate about precision oncology and empowering patients through education.

• Entrepreneurial mindset with ability to work in a fast-paced, evolving environment.

Why Natera:

• Shape the future of cancer care with groundbreaking technology.

• Work with a global team united by a mission to improve patient outcomes.

• Competitive compensation, career growth opportunities, and flexible working culture